We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Fluorescence Assay Determines Gram Sign in Living Bacteria

By HospiMedica staff writers
Posted on 30 Nov 2006
A bacterial Gram stain kit provides a novel one-step fluorescence assay, which can determine Gram sign in living bacteria in minutes, without the use of fixatives.

The kit includes mixtures of the green fluorescent syto 9 and red fluorescent hexidium iodide nucleic acid stains. More...
The syto 9 stain labels both live Gram-negative and Gram-positive bacteria, whereas hexidium iodide preferentially labels live Gram-positive bacteria. In Gram-positive bacteria that are exposed to both dyes, the hexidium iodide stain effectively displaces the syto 9 stain. Thus, when a mixed population of live Gram-negative and Gram-positive bacteria is stained with this mixture of dyes, the Gram-negative bacteria fluoresce green and the Gram-positive bacteria fluoresce red. Dead bacteria do not exhibit predictable staining patterns.

This live BacLight bacterial Gram stain kit, developed by Molecular Probes (Invitrogen, Carlsbad, California, USA), overcomes several of the problems inherent in fixation-dependent procedures. The kit reagents exhibit low intrinsic background fluorescence. Gram-negative and Gram-positive organisms can be easily differentiated using any fluorescence microscope equipped with a standard fluorescein longpass optical filter set, or by flow cytometry. By using the kit, it is possible to mount stained bacteria on filter membranes and perform the direct epifluorescence filter technique (DEFT).

The original Gram stain involves a number of steps: heat fixation of the bacteria, a two-step staining protocol, alcohol extraction, and counterstaining. Over the years, several improved Gram-staining techniques were developed, but most involve cell fixation or cell-membrane permeabilization steps that kill the bacteria being tested. In addition, fixation steps can be a significant drawback if the bacteria need to be characterized further.



Related Links:
Molecular Probes

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
X-Ray Meter
Cobia SENSE
OR Table Accessory
Angular Accessory Rail
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.